Stille AB
STO:STIL
STIL's latest stock split occurred on Jun 24, 2008
The company executed a 1-for-100 stock split, meaning that for every 100 shares held, investors received 1 new share.
The adjusted shares began trading on Jun 24, 2008. This was STIL's 2nd stock split, following the previous one in Jul 25, 2007.
WTO
Stille AB
Glance View
Stille AB engages in the development and sale of medical equipment. The company is headquartered in Torshaella, Sodermanlands. The product portfolio is divided into two business lines. The Surgery business area develops, produces and markets handcrafted, forged surgical instruments for all fields of open surgery, with an emphasis on cardiovascular surgery, and reconstructive and aesthetic plastic surgery. Its products include scissors, forceps, artery forceps, needle holders and clamps, among others. The Patient Positioning area develops and manufactures two main groups of procedure-specific specialized tables for cardiovascular surgery and gynecology, urology and urodynamic examinations. As of December 31, 2011, the Company had two wholly owned subsidiaries, Stille Surgical Inc. and Stille Incentive AB. As of December 30, 2011, the it's largest shareholder was Linc Invest AB (39.81%). On September 2, 2013, the Company sold its business unit, Sonesta, to ADDvise Lab Solutions publ AB.
You don't have any saved screeners yet